Pivotal Research Downgrades Balchem (BCPC) to Hold

May 5, 2019 1:12 PM

Pivotal Research analyst Timothy Ramey downgraded Balchem (NASDAQ: BCPC) from Buy to Hold with a price target of $100.00.The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found